Physician profile
Peter Strogov
NPI 1295964682
$535.53
in general payments reported to CMS, 2019-2025
13 companies · $62.53 in 2025
The $62.53 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $104 · 2021: $58.63 · 2022: $78.34 · 2023: $17.96 · 2024: $21.16 · 2025: $62.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $101.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $149.98 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $76.01 | 2019-2022 | |
| Pfizer INC. | $55.00 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $47.39 | 2025 | |
| Neos Therapeutics, Lp | $43.78 | 2019-2020 | |
| Genentech USA, INC. | $40.31 | 2019-2020 | |
| Qol Medical, LLC | $32.20 | 2022 | |
| Roche Diagnostics Corporation | $17.94 | 2019 | |
| Seqirus USA INC | $17.29 | 2021 | |
| Phadia US INC. | $15.75 | 2019 | |
| Sanofi Pasteur INC. | $15.14 | 2025 | |
| Shire North American Group INC | $12.83 | 2019 | |
| Neurelis, INC. | $11.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Strogov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.